Clicky

ResMed Inc. (CHESS)  (RMD)

Description: ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions. The Company produces Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP) and AutoSet systems for the titration and treatment of SDB.


Keywords: Medicine Software Disease Medical Device Medical Equipment Software Application Disorders Diagnostic Products Chronic Obstructive Pulmonary Disease Sleep Disorders Sleep Sleep Apnea Obstructive Sleep Apnea Copd Oxygen Concentrator Positive Airway Pressure Continuous Positive Airway Pressure Headgear Respiratory Disorders Dental Devices Neuromuscular Disease Resmed Cloud Based Software Applications Mask Systems Cloud Based Software Informatics Solutions Sleep Disordered Breathing Sleep And Breathing

Home Page: www.resmed.com

RMD Technical Analysis

Allianz Funds
,

Phone: 858 836 5000


Officers

Name Title
Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD Founder & Non-Exec. Chairman
Mr. Michael J. Farrell BE, MBA, SM CEO & Director
Mr. Robert A. Douglas Pres & COO
Mr. Brett A. Sandercock Chief Financial Officer
Mr. David B. Pendarvis Chief Admin. Officer, Global Gen. Counsel & Corp. Sec.
Mr. Kaushik Ghoshal Pres of SaaS Bus.
Ms. Urvashi Tyagi Chief Technology Officer
Ms. Constance C. Bienfait Director of Investor Relations
Ms. Amy Wakeham VP of Investor Relations & Corp. Communications
Ms. Vered Keisar Chief People Officer

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 35.461
Trailing PE: 39.47
Price-to-Book MRQ: 9.4564
Price-to-Sales TTM: 12.8402
IPO Date:
Fiscal Year End: June
Full Time Employees: 8160
Back to stocks